Literature DB >> 18579026

Myoclonus.

Victoria C Chang1, Steven J Frucht.   

Abstract

Myoclonus is a hyperkinetic movement disorder characterized by quick, involuntary jerks. It encompasses a vast range of etiologies and widespread anatomic locations. Treatment frequently requires multiple agents and is often only partially beneficial. These patients pose a considerable challenge for the clinician, further complicated by the fact that many of the treatment choices lack evidence-based support. In the past few years, publications regarding therapy have been largely observational case reports or series. Although the literature on treatment of cortical myoclonus appears to be growing, evidence regarding myoclonus of noncortical origin is less well established. Investigation of more satisfactory treatments is needed, as this condition can be disturbing, debilitating, and sometimes harmful for patients. Continuing investigations are using various animal models (mostly of posthypoxic myoclonus), electrophysiologic studies, new imaging techniques such as diffusion tensor imaging, and genetic studies. Meanwhile, the clinical approach to diagnosing and classifying myoclonus remains largely unchanged. This review updates readers on current investigations and suggests guidelines for diagnosing and treating myoclonus.

Entities:  

Year:  2008        PMID: 18579026     DOI: 10.1007/s11940-008-0024-y

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  39 in total

1.  Successful treatment of truncal myoclonus.

Authors:  Alon Abraham; Cogan Elena; Eldad Melamed; Ruth Djaldetti
Journal:  Mov Disord       Date:  2007-05-15       Impact factor: 10.338

2.  Dramatic effect of ethosuximide on epileptic negative myoclonus: implications for the neurophysiological mechanism.

Authors:  H Oguni; T Uehara; T Tanaka; M Sunahara; M Hara; M Osawa
Journal:  Neuropediatrics       Date:  1998-02       Impact factor: 1.947

Review 3.  Myoclonus and transcranial magnetic stimulation.

Authors:  J-P Lefaucheur
Journal:  Neurophysiol Clin       Date:  2007-01-17       Impact factor: 3.734

4.  Myoclonus-dystonia syndrome with severe depression is caused by an exon-skipping mutation in the epsilon-sarcoglycan gene.

Authors:  Anjum Misbahuddin; Mark Placzek; Graham Lennox; Jan-Willem Taanman; Thomas T Warner
Journal:  Mov Disord       Date:  2007-06-15       Impact factor: 10.338

5.  Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo.

Authors:  M Koskiniemi; B Van Vleymen; L Hakamies; S Lamusuo; J Taalas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-03       Impact factor: 10.154

6.  Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations.

Authors:  L J Thal; N S Sharpless; L Wolfson; R Katzman
Journal:  Ann Neurol       Date:  1980-06       Impact factor: 10.422

7.  Segmental myoclonus. Clinical and pharmacologic study.

Authors:  J Jankovic; R Pardo
Journal:  Arch Neurol       Date:  1986-10

8.  Axial myoclonus of propriospinal origin.

Authors:  P Brown; P D Thompson; J C Rothwell; B L Day; C D Marsden
Journal:  Brain       Date:  1991-02       Impact factor: 13.501

9.  Levetiracetam in three cases of progressive myoclonus epilepsy.

Authors:  Savvas Papacostas; Elena Kkolou; Eleftherios Papathanasiou
Journal:  Pharm World Sci       Date:  2007-01-23
View more
  2 in total

Review 1.  Definition and classification of hyperkinetic movements in childhood.

Authors:  Terence D Sanger; Daofen Chen; Darcy L Fehlings; Mark Hallett; Anthony E Lang; Jonathan W Mink; Harvey S Singer; Katharine Alter; Hilla Ben-Pazi; Erin E Butler; Robert Chen; Abigail Collins; Sudarshan Dayanidhi; Hans Forssberg; Eileen Fowler; Donald L Gilbert; Sharon L Gorman; Mark E Gormley; H A Jinnah; Barbara Kornblau; Kristin J Krosschell; Rebecca K Lehman; Colum MacKinnon; C J Malanga; Ronit Mesterman; Margaret Barry Michaels; Toni S Pearson; Jessica Rose; Barry S Russman; Dagmar Sternad; Kathy J Swoboda; Francisco Valero-Cuevas
Journal:  Mov Disord       Date:  2010-08-15       Impact factor: 10.338

2.  Acute posthypoxic myoclonus after cardiopulmonary resuscitation.

Authors:  Aline Bouwes; Daniël van Poppelen; Johannes H T M Koelman; Michael A Kuiper; Durk F Zandstra; Henry C Weinstein; Selma C Tromp; Eveline G J Zandbergen; Marina A J Tijssen; Janneke Horn
Journal:  BMC Neurol       Date:  2012-08-01       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.